Document Detail


Detection of myocardial viability with 99mTc-labelled myocardial perfusion agents.
MedLine Citation:
PMID:  8681015     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Detection of myocardial viability is an important clinical issue in the time course of acute myocardial infarction and in chronic coronary artery disease. The wide availability of myocardial revascularization procedures requires a refinement of specific indications for revascularization whenever left ventricular failure is the most prominent feature of coronary artery disease. In this instance the risk/benefit ratio has to be attentively evaluated with diagnostic tests able to predict favourable changes in regional and global left ventricular function, symptoms, life quality, risk of adverse events and ultimately prognosis. 201Tl has been shown to provide clinically televant information regarding the presence of myocardial viability in patients with extensive regional or global ventricular dysfunction. However, the increasing use of 99mTc labeled myocardial perfusion agents requires a careful evaluation of diagnostic and predictive accuracy of these agents also for the issue of myocardial viability. The widely accepted opinion of a lower predictive accuracy of these agents compared to 201Tl could be no longer true. The available clinical and experimental data indicate, at least for 99mTc-sestamibi, a comparable accuracy when independent and clinically relevant gold standard of viability like post-revascularization functional recovery is considered. Preliminary data indicate that protocols, like nitrate administration, slow infusion or delayed imaging, and accurate quantitation of 99mTc-sestamibi SPECT studies could enhance the predictive accuracy to a level comparable or even better than that of 201Tl and similar to the more demanding PET technology.
Authors:
G Bisi; V Podio; R Sciagrà
Related Documents :
10894915 - Utility of positron emission tomography in predicting improved left ventricular ejectio...
18836375 - Prognostic performance of quantitative pet tools for stratification of patients with is...
17667445 - Right ventricular wall "ischemia" findings using a dual isotope protocol.
7767505 - Estimation of hydrogen peroxide plasma levels in patients evaluated for coronary heart ...
9393475 - Primary critical ischemia time in the hairless mouse ear.
8015325 - A population-based study of stroke in the setting of mitral valve prolapse: risk factor...
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  The quarterly journal of nuclear medicine : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR)     Volume:  40     ISSN:  1125-0135     ISO Abbreviation:  Q J Nucl Med     Publication Date:  1996 Mar 
Date Detail:
Created Date:  1996-08-21     Completed Date:  1996-08-21     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  9512274     Medline TA:  Q J Nucl Med     Country:  ITALY    
Other Details:
Languages:  eng     Pagination:  68-75     Citation Subset:  IM    
Affiliation:
Department of Internal Medicine, University of Turin, Italy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Coronary Circulation*
Coronary Disease / physiopathology,  radionuclide imaging*
Heart / radionuclide imaging*
Humans
Myocardial Stunning / radionuclide imaging
Organotechnetium Compounds / diagnostic use*
Technetium Tc 99m Sestamibi / diagnostic use
Chemical
Reg. No./Substance:
0/Organotechnetium Compounds; 109581-73-9/Technetium Tc 99m Sestamibi

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Assessment of myocardial perfusion and metabolism for assessment of myocardial viability.
Next Document:  Quantitative assessment of myocardial perfusion: is it of clinical relevance?